SEC 8-K News

2024-07-01 07:37:41

Carisma Therapeutics Inc. has announced changes to its board of directors. On June 26, 2024, Regina Hodits, Ph.D. and Björn Odlander, M.D., Ph.D., both decided to resign from the board with an effective date of June 30, 2024, citing other professional commitments and no disagreements with the company. Concurrently, Marella Thorell and David Scadden, M.D. have been elected to the board with their roles commencing on June 30, 2024. They will serve as Class III directors until the 2026 annual meeting. Thorell will chair the audit committee, while Dr. Scadden will lead the science committee. They will receive annual cash compensation and a stock option to purchase Company shares.

List of Names: - Regina Hodits, Ph.D. - Björn Odlander, M.D., Ph.D. - Marella Thorell - David Scadden, M.D. - Steven Kelly